Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

LYEL Stock Annual Income Statement. Download in Excel

Lyell Immunopharma Inc

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

1.09
 
USD
  
0.01
  
(0.93%)
Previous close: 1.08  Open: 1.09  Bid: 1.07  Ask: 1.13
52 week range    
1.06   
   3.26
Mkt Cap: 289 M  Avg Vol (90 Days): 666,791
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 11th October 2024

Stock Rankings

38
MarketXLS Rank
60
Value
7
Technical
47
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

LYEL Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23
Basic EPS from continuing operations-1.84-0.74-0.93
Basic EPS total-1.84-0.74-0.93
Basic weighted shares outstanding135918.0247 M251 M
Depreciation14 M18 M20 M
DepreciationAndAmortization14 M18 M20 M
Diluted EPS total-1.84-0.74-0.93
Diluted normalized net income/share-1.84-0.74-0.93
Diluted weighted shares outstanding135918.0247 M251 M
GainOnSaleOfPPE308000.0
GainOnSaleOfSecurity3 M
GeneralAndAdministrativeExpense89 M117 M67 M
Gross operating profit11 M85 M130000.0
Income before tax-250 M-183 M-235 M
Income restructuring and M&A6 M
Interest income1 M7 M23 M
MiscOtherSpecialCharges-161000.02 M2 M
Net income from total operations-250 M-183 M-235 M
NetIncomeCommonStockholders-250 M-183 M-235 M
NetIncomeContinuousOperations-250 M-183 M-235 M
NetNonOperatingInterestIncomeExpense1 M7 M23 M
Operating income-215 M-187 M-247 M
Operating income before depreciation (EBITDA)-235 M-166 M-214 M
OperatingExpense225 M272 M247 M
Other income net37 M3 M-11 M
OtherGandA89 M117 M67 M
OtherImpairmentOfCapitalAssets36 M
OtherOperatingExpenses-2 M-5 M-3 M
Research & development expense139 M159 M183 M
ResearchExpense139 M159 M183 M
RestructringAndMnAIncome6 M
Selling Gen & administrative expense89 M117 M67 M
Special income/charges-5 M
Total Income available for interest expense (EBIT)-250 M-183 M-235 M
Total common shares outstanding245 M250 M254 M
Total net income-250 M-183 M-235 M
Total ordinary shares256 M256 M256 M
Total revenues11 M85 M130000.0
TotalExpenses225 M272 M247 M
TotalRevenue11 M85 M130000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University